ArticleJournal of clinical medicine2026

Effects of Semaglutide on Cardiometabolic Risk in People with Obesity, With and Without Type 2 Diabetes: A Retrospective Observational Study.

Loredana Deaconu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.